Senior insider sale
Chief Legal Officer & Corp Sec at ACUMEN PHARMACEUTICALS, INC. — senior position signals high conviction
$205.5K
101.35K shares
MEISNER DEREK M plans to sell 101.35K shares of ACUMEN PHARMACEUTICALS, INC. valued at approximately $205.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Exercise of employee stock options
Broker assisted cashless exercise
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/27/2026 | Exercise of employee stock options Broker assisted cashless exercise | 15.09K | — |
| Total | 15.09K | ||
Completed
Units to sell
5.63K
Market value
$10.5K
Units to sell
1.05K
Market value
$1.9K
Units to sell
2.25K
Market value
$4.1K
Units to sell
8.55K
Market value
$14.7K
Units to sell
5.20K
Market value
$9.2K
Units to sell
36.91K
Market value
$67.2K
Units to sell
11.77K
Market value
$23.4K
Units to sell
10.90K
Market value
$21.4K
Units to sell
4K
Market value
$7.8K
Planned — Approximate Date
Units to sell
15.09K
Market value
$45.3K
Units
101.35K
Value
$205.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/23/2026 | 5.63K | $10.5K | — | Completed |
1/22/2026 | 1.05K | $1.9K | — | Completed |
1/21/2026 | 2.25K | $4.1K | — | Completed |
1/12/2026 | 8.55K | $14.7K | — | Completed |
1/9/2026 | 5.20K | $9.2K | — | Completed |
1/8/2026 | 36.91K | $67.2K | — | Completed |
1/7/2026 | 11.77K | $23.4K | — | Completed |
1/6/2026 | 10.90K | $21.4K | — | Completed |
1/5/2026 | 4K | $7.8K | — | Completed |
| Planned — Approximate Date | ||||
1/27/2026 | 15.09K | $45.3K | NASDAQ | Planned |
| Total | 101.35K | $205.5K | ||